Skip to main content

Table 3 Differences in CD4+ T-lymphocyte percentages among 40 early treated children and 91 children receiving deferred treatment, by age

From: Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy

Age (years)

  

<1

1

2

3

4

5

6

7

8

9

Median CD4+ T-lymphocyte percentage (IQR)

Early treated children

36 (28–50)

38 (35–43)

38 (35–42)

36 (28–40)

35 (32–41)

35 (31–42)

36 (28–39)

38 (31–39)

37 (32–38)

35 (28–42)

 

Not-early treated children

34 (26–45)

31(23–43)

32 (24–39)

33 (27–40)

30 (22–37)

32 (25–38)

33 (35–37)

32 (26–37)

32 (27–37)

33 (24–37)

 

P*

0.126

0.003

0.001

0.021

0.015

0.107

0.116

0.090

0.126

0.647

  1. Note: IQR: interquartile range; *by Mann-Whitney test.